SG11201704699YA - Carrier molecule compositions and related methods - Google Patents
Carrier molecule compositions and related methodsInfo
- Publication number
- SG11201704699YA SG11201704699YA SG11201704699YA SG11201704699YA SG11201704699YA SG 11201704699Y A SG11201704699Y A SG 11201704699YA SG 11201704699Y A SG11201704699Y A SG 11201704699YA SG 11201704699Y A SG11201704699Y A SG 11201704699YA SG 11201704699Y A SG11201704699Y A SG 11201704699YA
- Authority
- SG
- Singapore
- Prior art keywords
- related methods
- carrier molecule
- molecule compositions
- compositions
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462088813P | 2014-12-08 | 2014-12-08 | |
| PCT/IB2015/002430 WO2016092365A1 (en) | 2014-12-08 | 2015-12-08 | Carrier molecule compositions and related methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201704699YA true SG11201704699YA (en) | 2017-07-28 |
Family
ID=56106788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201704699YA SG11201704699YA (en) | 2014-12-08 | 2015-12-08 | Carrier molecule compositions and related methods |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160166703A1 (de) |
| EP (1) | EP3230302A4 (de) |
| JP (1) | JP6821866B2 (de) |
| KR (1) | KR102497642B1 (de) |
| CN (1) | CN107427548A (de) |
| AU (1) | AU2015359030B2 (de) |
| CA (1) | CA2970136C (de) |
| HK (1) | HK1245302A1 (de) |
| IL (1) | IL252738B (de) |
| SG (1) | SG11201704699YA (de) |
| WO (1) | WO2016092365A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015359030B2 (en) | 2014-12-08 | 2020-10-22 | Jysk Skin Solutions Pte. Ltd. | Carrier molecule compositions and related methods |
| AU2017326253B2 (en) | 2016-09-13 | 2021-10-21 | Allergan, Inc. | Stabilized non-protein clostridial toxin compositions |
| CN110612093A (zh) * | 2017-02-07 | 2019-12-24 | 麦欧赛普特股份有限公司 | 局部制剂和方法 |
| US20210162026A1 (en) | 2017-08-28 | 2021-06-03 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
| CN111278420B (zh) * | 2017-09-18 | 2023-09-19 | 安尼根有限公司 | 活性物质-六肽复合体及包含其的化妆品组合物 |
| EP3703738A4 (de) * | 2017-11-03 | 2021-09-08 | ReVance Therapeutics, Inc. | Botulinumtoxin-formulierungen und verfahren zu ihrer verwendung bei plantarem fersensporn mit verlängerter wirkungsdauer |
| CN111655279A (zh) * | 2017-12-04 | 2020-09-11 | 雷文斯治疗公司 | 具有高应答率和长效应持续时间的可注射的肉毒杆菌毒素制剂及其使用方法 |
| CN109091413A (zh) * | 2018-10-31 | 2018-12-28 | 成都元素平衡生物科技有限公司 | 一种透皮性a型肉毒毒素、其制备方法及应用 |
| KR20200080179A (ko) * | 2018-12-26 | 2020-07-06 | 아미코젠주식회사 | 아세틸콜린 수용체 저해 펩타이드 및 이의 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6780846B1 (en) * | 1999-09-27 | 2004-08-24 | Elan Corporation, Plc | Membrane translocating peptide drug delivery system |
| CA2445947A1 (en) * | 2001-04-30 | 2002-11-07 | Targeted Genetics Corporation | Lipid-comprising drug delivery complexes and methods for their production |
| EP1729821B1 (de) * | 2004-03-03 | 2013-07-17 | ReVance Therapeutics, Inc. | Zusammensetzungen und methoden zur topischen anwendung und transdermalen verabreichung von botulinus toxinen |
| WO2005117928A1 (en) * | 2004-05-30 | 2005-12-15 | Cemines, Inc. | Compositions and methods for the treatment of skin cancer |
| RU2007136616A (ru) * | 2005-03-03 | 2009-04-10 | Риванс Терапьютикс, Инк. (Us) | Композиция и способ для местного применения и чрескожного введения ботулинового токсина |
| EP1984399A4 (de) * | 2006-02-10 | 2010-03-03 | Univ California | Transduzierbare abgabe von sirana mittels dsrna-bindedomänenfusionen an ptd/cpps |
| AU2007340162B2 (en) * | 2006-12-29 | 2013-08-01 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT |
| WO2010039088A1 (en) | 2008-09-16 | 2010-04-08 | Kariem Ahmed | Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| PT2413947T (pt) * | 2009-04-01 | 2020-05-28 | Revance Therapeutics Inc | Métodos e composições para tratar condições de pele associadas à hiper-reatividade vascular |
| US8715736B2 (en) * | 2009-04-30 | 2014-05-06 | Florida Agricultural And Mechanical University | Nanoparticle formulations for skin delivery |
| WO2012090150A2 (en) * | 2010-12-27 | 2012-07-05 | Compugen Ltd | New cell-penetrating peptides and uses thereof |
| US20140335192A1 (en) * | 2013-05-09 | 2014-11-13 | Kipperman, RM, Ch 7 BK Trustee for Traversa Therap | Delivery of rna interfering agents |
| AU2015359030B2 (en) | 2014-12-08 | 2020-10-22 | Jysk Skin Solutions Pte. Ltd. | Carrier molecule compositions and related methods |
-
2015
- 2015-12-08 AU AU2015359030A patent/AU2015359030B2/en active Active
- 2015-12-08 WO PCT/IB2015/002430 patent/WO2016092365A1/en active Application Filing
- 2015-12-08 US US14/963,155 patent/US20160166703A1/en not_active Abandoned
- 2015-12-08 CA CA2970136A patent/CA2970136C/en active Active
- 2015-12-08 SG SG11201704699YA patent/SG11201704699YA/en unknown
- 2015-12-08 JP JP2017531629A patent/JP6821866B2/ja active Active
- 2015-12-08 EP EP15868632.9A patent/EP3230302A4/de active Pending
- 2015-12-08 CN CN201580076045.XA patent/CN107427548A/zh active Pending
- 2015-12-08 KR KR1020177018816A patent/KR102497642B1/ko active IP Right Grant
-
2017
- 2017-06-07 IL IL252738A patent/IL252738B/en unknown
- 2017-12-13 US US15/841,059 patent/US11484595B2/en active Active
-
2018
- 2018-04-17 HK HK18104955.5A patent/HK1245302A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016092365A1 (en) | 2016-06-16 |
| CA2970136C (en) | 2023-07-04 |
| EP3230302A4 (de) | 2018-10-10 |
| IL252738A0 (en) | 2017-08-31 |
| AU2015359030A1 (en) | 2017-07-13 |
| KR102497642B1 (ko) | 2023-02-09 |
| AU2015359030B2 (en) | 2020-10-22 |
| US11484595B2 (en) | 2022-11-01 |
| EP3230302A1 (de) | 2017-10-18 |
| JP2018507169A (ja) | 2018-03-15 |
| HK1245302A1 (zh) | 2018-08-24 |
| CA2970136A1 (en) | 2016-06-16 |
| IL252738B (en) | 2021-10-31 |
| US20180214557A1 (en) | 2018-08-02 |
| CN107427548A (zh) | 2017-12-01 |
| JP6821866B2 (ja) | 2021-01-27 |
| KR20170093925A (ko) | 2017-08-16 |
| US20160166703A1 (en) | 2016-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2535253B (en) | Compositions and methods | |
| HK1245302A1 (zh) | 載體分子組合物及相關方法 | |
| GB201421379D0 (en) | Molecule | |
| GB201417828D0 (en) | New methods and compositions | |
| IL246879B (en) | Preparations of Epilimod and methods of using them | |
| HK1214967A1 (zh) | 組合物 | |
| HK1218859A1 (zh) | 組合物 | |
| GB201403017D0 (en) | Composition | |
| HK1244432A1 (zh) | 組合物 | |
| SG11201605753VA (en) | Nutrition composition | |
| GB201414910D0 (en) | Composition | |
| GB201403561D0 (en) | Composition | |
| RS59627B1 (sr) | Kompozicija amina maskiranog mirisa | |
| GB201414555D0 (en) | Composition | |
| GB201410493D0 (en) | Composition | |
| GB201519442D0 (en) | Composition | |
| GB201405657D0 (en) | Additive carrying composition | |
| ZA201606127B (en) | Composition | |
| GB201420628D0 (en) | Composition | |
| GB201415483D0 (en) | Composition | |
| GB201402915D0 (en) | Compositions and methods | |
| GB201404390D0 (en) | Composition | |
| GB201402648D0 (en) | Composition | |
| IL250781A0 (en) | preparation | |
| RS56048B1 (sr) | Usavršene kompozicije i postupci za fruktoboratne komplekse |